MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$217,049K
Marketable securities
$35,949K
Inventory
$4,479K
Prepaid expenses and
other current assets
$3,527K
Accounts receivable
$573K
Total current assets
$261,577K
Goodwill
$17,351K
Intangible asset, net
$9,250K
Right-of-use assets
$1,409K
Other assets
$692K
Property and equipment,
net
$182K
Total assets
$290,461K
Total liabilities and
stockholders equity
$290,461K
Total stockholders
equity
$186,290K
Total liabilities
$104,171K
Accumulated deficit
-$594,554K
Accumulated other
comprehensive loss
-$109K
Additional paid-in capital
$780,862K
Long-term debt, including
accretion, net of discount
$76,291K
Total current
liabilities
$25,757K
Warrant liability
$977K
Deferred revenue
$621K
Other liabilities
$525K
Common stock, 0.001 par
value, 500,000,000...
$91K
Accrued expenses
$18,603K
Accounts payable
$5,696K
Current portion of lease
liability
$994K
Deferred revenue
$464K
Back
Back
Balance Sheet
source: myfinsight.com
X4 Pharmaceuticals, Inc (XFOR)
X4 Pharmaceuticals, Inc (XFOR)